Skip to content

Health Systems and Private Practices

Working with Providers to improve outcomes

Our aim is to partner with health systems and private practices to implement our platform on a wider scale. Through partnerships with medical providers with a focus on constantly improving their heart failure diagnostic procedures and technology, we hope that more patients will receive the treatment they need.

Partnering with Ultromics means working with cutting-edge, FDA-approved technology that has been clinically validated through peer-reviewed publications and trials to improve precision and time-to-diagnosis of heart failure.

Our Experience Partnering With Health Systems and Private Practice

We have a strong history of collaboration with Mayo Clinic, including the creation of a research program to apply AI forecasting to heart failure. Our combined team used AI analysis of ultrasound heart scans to identify the markers of heart failure and develop an image analysis risk prediction model to alert doctors to potential heart failure.

Click here to learn more

 

Mayo Clinic

We have a strong history of collaboration with Mayo Clinic, including the creation of a research program to apply AI forecasting to heart failure. Our combined team used AI analysis of ultrasound heart scans to identify the markers of heart failure and develop an image analysis risk prediction model to alert doctors to potential heart failure.

mayo clinic

Amarillo Cardiology Center

The Cardiology Center of Amarillo adopted EchoGo® Heart Failure in 2023 to support the detection of patients with heart failure with preserved ejection fraction (HFpEF).
HFpEF is an underdiagnosed problem that is common and causes significant illness. Diagnosis can be the most difficult part of the process. Using EchoGo® Heart Failure has added a novel component which has helped Amarillo’s screening and diagnosis process.

 

 

National Health Service UK (NHS)

Ultromics undertook a study in collaboration with Buckinghamshire Healthcare NHS Trust, Great Western Hospitals NHS Foundation Trust, Milton Keynes University Hospital NHS Foundation Trust, John Radcliffe Hospital, Oxford; Royal United; Royal Berkshire NHS Foundation Trust, and St George’s University Hospitals NHS Foundation Trust, London to establish whether the diagnostic accuracy of Stress Echocardiography (SE) can be increased by left ventricular (LV) assessment with AI.

Thanks to our collaboration with these centers, the study confirmed that AI calculation of left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) by contouring of contrast-enhanced and unenhanced SEs at rest and stress was feasible and independently improved the identification of obstructive coronary artery disease beyond conventional methods alone.

NHS-1

 

Partner with us

If you are looking for partnerships in the area of heart failure we would like to hear from you.